Skip to main content
Log in

Moya moya vasculopathy and MECP2 duplication syndrome

  • Review
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Background

Moya moya type vasculopathy (MMV) is a rare disorder in which there is narrowing of bilateral intracranial carotid arteries (Scott and Smith in New Engl J Med 360(12):1226–1237, 2009). MECP2 duplication syndrome (MDS) is a rare genetic disorder that is caused by genetic duplications on Xq28 chromosome (Expanding the clinical picture of the MECP2 duplication syndrome. (Lim et al. in Clin Genet 91(4):557–563, 2017). Both disorders are rare and have not been described together in association.

Case Presentation

Interestingly, we present a child with both MDS and MMV. Upon genetic testing, there was found to be a large, de novo duplication sequence in the patient’s genome. Possible correlation between our patient’s extensive genetic mutation and MMV has been evaluated.

Conclusion

Our literature search disclosed no other known patients with both MDS and MMV. Patients with MDS should be monitored carefully for signs or symptoms of vasculopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Scott, Smith ER (2009) Moyamoya disease and moyamoya syndrome. New Engl J Med 360(12):1226–1237. https://doi.org/10.1056/NEJMra0804622

    Article  CAS  PubMed  Google Scholar 

  2. Lim Downs J, Wong K, Ellaway C, Leonard H (2017) Expanding the clinical picture of the MECP2 duplication syndrome. Clin Genet 91(4):557–563. https://doi.org/10.1111/cge.12814

    Article  CAS  PubMed  Google Scholar 

  3. Ta D et al (2022) A brief history of MECP2 duplication syndrome: 20-years of clinical understanding - Orphanet Journal of Rare Diseases. BioMed Central. https://doi.org/10.1186/s13023-022-02278-w

    Article  Google Scholar 

  4. Ramocki MB (2010) The MECP2 duplication syndrome. Wiley Online Library. https://doi-org.proxy.libraries.rutgers.edu/10.1002/ajmg.a.33184

  5. Starke RM et al (2012) Moyamoya disorder in the United States. Neurosurgery 71(1):93–99. https://doi.org/10.1227/neu.0b013e318253ab8e

    Article  PubMed  Google Scholar 

  6. Van Esch H (2012) MECP2 duplication syndrome. Molecular Syndromology, S. Karger AG, 2012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366699/

  7. Peters SU et al (2015) Diurnal salivary cortisol and regression status in MECP2 duplication syndrome. J Child Neurol. https://doi-org.proxy.libraries.rutgers.edu/10.1177/0883073815585577

  8. Tarasów Kułakowska A, Lukasiewicz A, Kapica-Topczewska K, Korneluk-Sadzyńska A, Brzozowska J, Drozdowski W (2011) Moyamoya disease: diagnostic imaging. Pol J Radiol 76(1):73–79

    PubMed  Google Scholar 

  9. Gupta A, Tyagi A, Romo M, Amoroso KC, Sonia F (2020) Moyamoya disease: a review of current literature. Cureus 12(8):e10141. https://doi.org/10.7759/cureus.10141

    Article  PubMed  PubMed Central  Google Scholar 

  10. Shoukat S, Itrat A, Taqui AM et al (2009) Moyamoya disease: a clinical spectrum, literature review and case series from a tertiary care hospital in Pakistan. BMC Neurol 9:15. https://doi.org/10.1186/1471-2377-9-15

    Article  PubMed  PubMed Central  Google Scholar 

  11. Berry JA, Cortez V, Toor H, Saini H, Siddiqi J (2020) Moyamoya: an update and review. Cureus 12(10):e10994. https://doi.org/10.7759/cureus.10994

    Article  PubMed  PubMed Central  Google Scholar 

  12. Peters Kundishora ST, Pinard A, Duran D, Panchagnula S, Barak T, Miyagishima DF, Dong W, Smith H, Ocken J, Dunbar A, Nelson-Williams C, Haider S, Walker RL, Li B, Zhao H, Thumkeo D, Marlier A, Duy PQ, Kahle KT (2021) DIAPH1 variants in non–East Asian patients with sporadic moyamoya disease. JAMA Neurol 78(8):993–1003. https://doi.org/10.1001/jamaneurol.2021.1681

    Article  PubMed  Google Scholar 

  13. Chibli R, Omor Y, Sebbouba NS, Hassani MRE, Jiddane M, Fikri M (2017) Moya moya disease: a rare cause of ischemic stroke in children: about a case. Pan Afr Med J 28:192–192. https://doi.org/10.11604/pamj.2017.28.192.8740

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mertens R, Graupera M, Gerhardt H, Bersano A, Tournier-Lasserve E, Mensah MA, Mundlos S, Vajkoczy P (2022) The genetic basis of moyamoya disease. Transl Stroke Res 13(1):25–45. https://doi.org/10.1007/s12975-021-00940-2

    Article  CAS  PubMed  Google Scholar 

  15. Guey S, Tournier-Lasserve E, Hervé D, Kossorotoff M (2015) Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 8:49–68. https://doi.org/10.2147/TACG.S42772

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

G.H., C.M., J.K., D.M., wrote the main manuscript text. J.R. prepared the imaging and titling for images. D.A. conducted genomic testing and dictated genetic report. G.H. and J.K., illustrated the figure and supplementary data. G.H. researched the supplementary data. R.G., J.K., C.M., D.A., helped research the treatment plan.

Corresponding author

Correspondence to Catherine Mazzola.

Ethics declarations

Consent to participate

Informed consent was obtained from patient’s legal guardian.

Conflict of interest

The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Previous presentations: This abstract and clinical case report are original and have not been submitted elsewhere in part or in whole.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 35 KB)

Appendix

Appendix

Fig. 1
figure 1

Diffusion imaging showing hyperintensity (arrow) in the anterior distribution of the right middle cerebral artery territory indicating an area of acute infarction

Fig. 2
figure 2

Apparent diffusion coefficient (ADC) showing low signal (arrow) in the anterior distribution of the right middle cerebral artery territory indicating an area of infarction

Fig. 3
figure 3

Axial T2-weighted image showing prominent and serpiginous signal flow voids of the left lenticulostriate vessels with absence of the left middle cerebral artery (rectangle)

Fig. 4
figure 4

Coronal maximum intensity projection showing prominent and serpiginous left lenticulostriate vessels with absence of the left middle cerebral artery (rectangle)

Fig. 5
figure 5

Genes within the overlying region and known affected regions on the Xq28 gene

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holover, G., Adams, D., Milligan, D. et al. Moya moya vasculopathy and MECP2 duplication syndrome. Childs Nerv Syst 40, 809–812 (2024). https://doi.org/10.1007/s00381-023-06139-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-023-06139-0

Keywords

Navigation